Click Here to reset your filters.
REGISTRATION
Category: Hematology
Type of Molecule: Protein
Rare indication
* Approved in the US for on-demand prophylaxis in adults and children and in perioperative management. EU is in registration for on-demand in adults.
Phase III
Category: Immunology
Type of Molecule: Protein
Rare indication
Phase III
Category: Oncology
Type of Molecule: Protein
Rare indication
Phase III
Category: Genetic Diseases
Type of Molecule: Protein
Rare indication
Phase III
Category: Genetic Diseases
Type of Molecule: Protein
Rare indication
Recent Approval
Category: Immunology
Rare indication
Phase III
Category: Genetic Diseases
Type of Molecule: Peptide
Rare indication
* Phase 2/3
Phase III
Category: GI / Metabolic
Type of Molecule: Peptide
Rare indication
Phase III
Category: Immunology
Type of Molecule: Antibodies (and derivatives)
Rare indication
Recent Approval
Category: Neuroscience
Type of Molecule: Small Molecule
Recent Approval
Category: GI / Metabolic
Type of Molecule: Protein
Rare indication
Phase III
Category: Hematology
Type of Molecule: Protein
Rare indication
Phase III
Category: Hematology
Type of Molecule: Protein
Rare indication
Phase II
Category: Oncology
Type of Molecule: Small Molecule
Rare indication
* Registration Study
Phase II
Category: Oncology
Type of Molecule: Small Molecule
Rare indication
Recent Approval
Category: Oncology
Rare indication
REGISTRATION
Category: Neuroscience
Type of Molecule: Small Molecule
Phase III
Category: GI / Metabolic
Type of Molecule: Small Molecule
Phase II
Category: Neuroscience
Type of Molecule: Protein
Rare indication
* SHP607 originally for RoP
Phase III
Category: Genetic Diseases
Type of Molecule: Protein
Rare indication
* Phase 2/3
Learn more at ShireTrials.com
Phase I
Category: Genetic Diseases
Type of Molecule: Protein
Rare indication
Learn more at ShireTrials.com
Phase III
Category: Genetic Diseases
Type of Molecule: Protein
Rare indication
Phase III
Category: Oncology
Type of Molecule: Small Molecule
Rare indication
Phase III
Category: GI / Metabolic
Type of Molecule: Small Molecule
Rare indication
* Granted breakthrough designation by FDA
Phase I
Category: Immunology
Type of Molecule: Protein Replacement
Rare indication
* rC1-INH previously being developed as SHP623 for HAE prophylaxis. After Phase 1 completion will be developed for NMO.
Phase II
Category: GI / Metabolic
Type of Molecule: Small Molecule
Rare indication
Learn more at ShireTrials.com
Phase II
Category: GI / Metabolic
Type of Molecule: Small Molecule
Rare indication
* Granted breakthrough designation by FDA
Phase II
Category: GI / Metabolic
Type of Molecule: Small Molecule
Learn more at ShireTrials.com
Phase I
Category: Genetic Diseases
Type of Molecule: Protein
Rare indication
Phase III
Category: Ophthalmology
Type of Molecule: Small Molecule
* Phase 3 expected to start in 2017
Phase III
Category: Genetic Diseases
Type of Molecule: Antibodies (and derivatives)
Rare indication
* Granted breakthrough designation by FDA
Phase II
Category: GI / Metabolic
Type of Molecule: Antibodies (and derivatives)
Phase II
Category: GI / Metabolic
Type of Molecule: Antibodies (and derivatives)
Phase II
Category: Immunology
Type of Molecule: Antibodies (and derivatives)
f.k.a. SM101
Phase I
Category: Hematology
Type of Molecule: Protein
f.k.a. BAX930
Rare indication
Phase III
Category: Hematology
Type of Molecule: Protein
Rare indication
Phase III
Category: Neuroscience
Type of Molecule: Small Molecule
* Phase 2/3